Curiolex at a glance.
“Curiolex provides comprehensive Drug Development services for small molecules and biologics. Focusing on CMC, formulation, pre-clinical, and clinical services, and project management, our team of experts provide the critical skills and experience to successfully bring drug development programs to completion.”
With a variety of successful domestic and international projects under our belt, Curiolex has the experience and resources to plan, manage and deliver drug development programs within set timescales and budgets. Our strength and advantage stems from an ability to integrate commercial acumen with comprehensive technical knowledge. We understand the importance of time- and cost-management, confidentiality, and reliability. Our Expert Team can manage all stages of drug development for our customers from early strategic planning, R&D design and execution, analytical design and execution, pilot development and process validations, to optimized final industrial production. Our services further include product registration assistance and commercialization. We offer flexible business models and adaptive project structures that optimize efficiency and performance. Confidentiality is assured.
With over 10 years of experience in Asia, and a network expanding Japan, Singapore, China and Taiwan, Curiolex has developed trusted partnerships with leading CDMOs and established reliable supply chains. We understand the local business culture and markets and can quickly react to deal with unforeseen problems and challenges. Curiolex is focused on serving the needs of our customers and we strive for clear and flexible business models.
CHRISTIAN A. SANDOVAL — Managing Director of Curiolex
Pharma Projects completed
Curiolex has successfully managed Pharma developments programs including 505(b)(2), IND, Class 1 and 2, and new to market API and Finished Dosage Forms (Modified Release formulations, ODT, Suspensions/ Emulsions/ Depot injections, Lyophilized, Solution/ Ophthalmic, etc.) generics.
Curiolex’s technical team of Process Chemists and Biochemists, Analytical staff and Production Managers expertly work with our CMO, CDMO, CRO and GLP partners to deliver scale-up manufacturing programs that meet regulatory requirements and our customer’s demands.
Curiolex has long-term partnerships with Agrochemicals manufacturers in China providing the best quality/price ratio to meet our customer’s requirements. Agrochemical product registration documentation, auditing, and administrative support is part of our service.
Curiolex provides Drug Discovery and Preclinical research related services. Our staff have decades of experience in CMC and formulation development, and manufacturing of traditional and complex dosage form drug products. 505(b)(2) (Class 2) program design, planning and execution are also possible. Via established strategic collaborations, Curiolex accommodates AI-driven discovery of microbiome-derived small molecule drug candidates. The technologies allow for exploration and collaboration in areas such as clinical data-derived functional gene screening, AI-based chemical space screening, in silico ligand and target selection, and understanding of microbiome effects on drug efficacy.
Curiolex Co. Ltd.